Cite
HARVARD Citation
Cahn, A. et al. (n.d.). Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD. Pulmonary pharmacology & therapeutics. pp. 69-77. [Online].